GeoVax Labs, Inc. (GOVX) stock
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.01−0.01 (-0.50%)
Close on Nov 17, 2026Market cap $14.81MP/E –Yield –
GeoVax Labs cash
Cash and short-term investments held at the end of each period.
GeoVax Labs's cash was $3.14M at Jun 30, 2026. For fiscal 2025 it was $3.09M, down 44.0% from the year before. Over ten years it grew 11.3% a year on average. The highest annual figure on record is $27.61M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.09M | -44.0% |
| FY2024 | Dec 31, 2024 | $5.51M | -14.7% |
| FY2023 | Dec 31, 2023 | $6.45M | -76.6% |
| FY2022 | Dec 31, 2022 | $27.61M | +141.7% |
| FY2021 | Dec 31, 2021 | $11.42M | +15.6% |
| FY2020 | Dec 31, 2020 | $9.88M | +3388.3% |
| FY2019 | Dec 31, 2019 | $283.34K | +9.1% |
| FY2018 | Dec 31, 2018 | $259.70K | -17.0% |
| FY2017 | Dec 31, 2017 | $312.73K | -31.1% |
| FY2016 | Dec 31, 2016 | $454.03K | -57.2% |
| FY2015 | Dec 31, 2015 | $1.06M | -3.7% |
| FY2014 | Dec 31, 2014 | $1.10M | -56.2% |
| FY2013 | Dec 31, 2013 | $2.51M | +142.7% |
| FY2012 | Dec 31, 2012 | $1.04M | -11.3% |
| FY2011 | Dec 31, 2011 | $1.17M | +8.2% |
| FY2010 | Dec 31, 2010 | $1.08M | -69.3% |
| FY2009 | Dec 31, 2009 | $3.52M | +60.5% |
| FY2008 | Dec 31, 2008 | $2.19M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.14M | +1.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.27M | -82.9% |
| Q4 FY2025 | Dec 31, 2025 | $3.09M | -44.0% |
| Q3 FY2025 | Sep 30, 2025 | $5.01M | -41.7% |
| Q2 FY2025 | Jun 30, 2025 | $3.09M | +98.1% |
| Q1 FY2025 | Mar 31, 2025 | $7.44M | +867.5% |
| Q4 FY2024 | Dec 31, 2024 | $5.51M | -14.7% |
| Q3 FY2024 | Sep 30, 2024 | $8.59M | -32.3% |
| Q2 FY2024 | Jun 30, 2024 | $1.56M | -91.2% |
| Q1 FY2024 | Mar 31, 2024 | $768.86K | -96.8% |
| Q4 FY2023 | Dec 31, 2023 | $6.45M | -76.6% |
| Q3 FY2023 | Sep 30, 2023 | $12.69M | -63.4% |
| Q2 FY2023 | Jun 30, 2023 | $17.79M | -42.4% |
| Q1 FY2023 | Mar 31, 2023 | $23.85M | +46.7% |
| Q4 FY2022 | Dec 31, 2022 | $27.61M | +141.7% |
| Q3 FY2022 | Sep 30, 2022 | $34.68M | +91.5% |
| Q2 FY2022 | Jun 30, 2022 | $30.90M | +58.2% |
| Q1 FY2022 | Mar 31, 2022 | $16.26M | -22.0% |
| Q4 FY2021 | Dec 31, 2021 | $11.42M | +15.6% |
| Q3 FY2021 | Sep 30, 2021 | $18.11M | +56.4% |
| Q2 FY2021 | Jun 30, 2021 | $19.54M | +2649.3% |
| Q1 FY2021 | Mar 31, 2021 | $20.84M | +9296.8% |
| Q4 FY2020 | Dec 31, 2020 | $9.88M | +3388.3% |
| Q3 FY2020 | Sep 30, 2020 | $11.58M | +1934.0% |
| Q2 FY2020 | Jun 30, 2020 | $710.68K | +228.4% |
| Q1 FY2020 | Mar 31, 2020 | $221.81K | +26.0% |
| Q4 FY2019 | Dec 31, 2019 | $283.34K | +9.1% |
| Q3 FY2019 | Sep 30, 2019 | $569.36K | +11.4% |
| Q2 FY2019 | Jun 30, 2019 | $216.41K | +13.3% |
| Q1 FY2019 | Mar 31, 2019 | $175.99K | -69.2% |
| Q4 FY2018 | Dec 31, 2018 | $259.70K | -17.0% |
| Q3 FY2018 | Sep 30, 2018 | $511.24K | +48.7% |
| Q2 FY2018 | Jun 30, 2018 | $190.97K | -76.8% |
| Q1 FY2018 | Mar 31, 2018 | $571.15K | +242.5% |
| Q4 FY2017 | Dec 31, 2017 | $312.73K | -31.1% |
| Q3 FY2017 | Sep 30, 2017 | $343.83K | -32.7% |
| Q2 FY2017 | Jun 30, 2017 | $822.60K | – |
| Q1 FY2017 | Mar 31, 2017 | $166.75K | – |
| Q4 FY2016 | Dec 31, 2016 | $454.03K | – |
| Q3 FY2016 | Sep 30, 2016 | $511.10K | – |
See a number that looks wrong?